{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:10:52Z","timestamp":1790115052787,"version":"4.0.1"},"reference-count":27,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Objectives: Outpatient antibiotic prescribing is a major driver of antimicrobial resistance, yet detailed long-term analyses of prescribing patterns in Croatia remain limited. This study aimed to analyze trends in outpatient antibiotic prescriptions issued in Croatian primary healthcare from 2015 to 2024, stratified by antibiotic class, substance, and the WHO AWaRe classification. Methods: A retrospective analysis of nationwide data on antibiotic prescriptions issued in primary care outpatient settings was conducted using the data from the Central Health Information System of the Republic of Croatia. All prescriptions for ATC group J01 antibiotics issued between 1 January 2015 and 31 December 2024 were included. The primary outcome was the annual number of issued outpatient antibiotic prescriptions, described overall and by substance. Annual counts were additionally expressed as a percentage of the 2015 baseline (index year = 100%) to enable the comparison across substances with different prescribing volumes. The prescriptions were classified according to the WHO AWaRe framework. Results: A total of 31,048,414 outpatient antibiotic prescriptions were issued between 2015 and 2024. Overall prescribing declined by 5.6% from 2015 to 2019, followed by a marked decrease of 21.0% in 2020, and subsequently rebounded to 3,338,235 prescriptions by 2024, a number virtually identical to pre-pandemic levels. Co-amoxiclav and azithromycin together accounted for 49.5% of all prescriptions. By 2024, prescribing third-generation cephalosporins increased by 281.9% compared to the 2015 levels, while prescribing amoxicillin decreased by 43.6% over the same period. The proportion of Access antibiotics declined from 64.7% in 2015 to 57.9% in 2024. Conclusions: The main challenge for antimicrobial stewardship in Croatia lies not only in overall prescribing volume but in prescribing composition. Targeted interventions are needed to reduce reliance on broad-spectrum agents and promote the use of narrower-spectrum first-line alternatives.<\/jats:p>","DOI":"10.3390\/idr18020036","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:14:17Z","timestamp":1776154457000},"page":"36","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trends in Outpatient Antibiotic Prescriptions Issued in Croatian Primary Healthcare, 2015\u20132024"],"prefix":"10.3390","volume":"18","author":[{"given":"Anamaria","family":"Jur\u010devi\u0107","sequence":"first","affiliation":[{"name":"Medical Informatics and Biostatistics Division, Croatian Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Dimnjakovi\u0107","sequence":"additional","affiliation":[{"name":"Medical Informatics and Biostatistics Division, Croatian Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-7438","authenticated-orcid":false,"given":"Rok","family":"\u010civljak","sequence":"additional","affiliation":[{"name":"Division for Respiratory Infections, University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10000 Zagreb, Croatia"},{"name":"Department for Infectious Diseases, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3325\/cmj.2023.64.272","article-title":"The burden of bacterial antimicrobial resistance in Croatia in 2019: A country-level systematic analysis","volume":"64","author":"Ikuta","year":"2023","journal-title":"Croat. Med. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jcpt.12610","article-title":"Antibacterials dispensed in the community comprise the majority of human antibiotic consumption","volume":"43","author":"Duffy","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_4","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2025, December 15). Antimicrobial Consumption in the EU\/EEA\u2014Annual Epidemiological Report 2024, Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-consumption-eueea-esac-net-annual-epidemiological-report-2024."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kasse, G.E., Humphries, J., Cosh, S.M., and Islam, M.S. (2024). Factors contributing to the variation in antibiotic prescribing among primary health care physicians: A systematic review. BMC Prim. Care, 25.","DOI":"10.1186\/s12875-023-02223-1"},{"key":"ref_6","first-page":"687","article-title":"Antibiotic resistance: What, why, where, when and how?","volume":"10","author":"Sabtu","year":"2021","journal-title":"Antibiotics"},{"key":"ref_7","unstructured":"World Health Organization (WHO) (2015). Global Action Plan on Antimicrobial Resistance, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241509763."},{"key":"ref_8","unstructured":"World Health Organization (WHO) (2025, December 15). AWaRe Classification of Antibiotics for Evaluation and Monitoring of Use 2023. Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.04."},{"key":"ref_9","unstructured":"Ministry of Health Croatia (2025, December 15). National Control Program for Antimicrobial Resistance 2017\u20132021 Zagreb, Available online: https:\/\/zdravlje.gov.hr\/programi-i-projekti\/nacionalni-programi-projekti-i-strategije\/ostali-programi\/nacionalni-program-za-kontrolu-otpornosti-bakterija-na-antibiotike-2017-2021\/2198."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/jac\/dkac028","article-title":"Global consumption of antimicrobials: Impact of the WHO Global Action Plan on Antimicrobial Resistance and COVID-19 pandemic","volume":"77","author":"Khouja","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_11","first-page":"2300604","article-title":"Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU\/EEA, 2022","volume":"28","author":"Leung","year":"2023","journal-title":"Eurosurveillance"},{"key":"ref_12","first-page":"2101020","article-title":"Decrease in community antibiotic consumption during the COVID-19 pandemic, EU\/EEA, 2020","volume":"26","author":"Pereira","year":"2021","journal-title":"Eurosurveillance"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cmi.2024.12.005","article-title":"Trends in antimicrobial consumption: Long-term impact of the COVID-19 pandemic","volume":"31","author":"Tsuzuki","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_14","unstructured":"(2025, December 15). Central Health Information System of the Republic of Croatia (CEZIH)\u2014Concept of the System. Available online: http:\/\/www.cezih.hr\/pzz\/dokumentacija\/01_00_CEZIH_koncept_sustava.pdf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13690-024-01427-w","article-title":"Community antibiotic consumption in the European Union\/European economic area: Late-pandemic rebound and seasonality analysis","volume":"82","author":"Vermeulen","year":"2024","journal-title":"Arch. Public Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2147\/IDR.S502126","article-title":"Rebound of antibiotic use and respiratory infections after COVID-19","volume":"18","author":"Ma","year":"2025","journal-title":"Infect. Drug Resist."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Koh, S.W.C., Low, S.H., Goh, J.C., and Hsu, L.Y. (2025). Increase in antibiotic utilisation in primary care post COVID-19 pandemic. Antibiotics, 14.","DOI":"10.3390\/antibiotics14030309"},{"key":"ref_18","unstructured":"Tambi\u0107 Andra\u0161evi\u0107, A., Baudoin, T., Vukeli\u0107, D., Mimica Matanovi\u0107, S., Bejuk, D., Pu\u017ee\u0161ki, D., Abram, M., Te\u0161ovi\u0107, G., Grgurev, Z., and Tomac, G. (2025, December 19). ISKRA Guidelines on Sore Throat: Diagnostic and Therapeutic Approach, Available online: https:\/\/iskra.bfm.hr\/wp-content\/uploads\/2020\/09\/ISKRA_grlobolja.pdf."},{"key":"ref_19","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2025, December 15). Antimicrobial Consumption in the EU\/EEA (ESAC-Net)\u2014Annual Epidemiological Report for 2023, Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-consumption-eueea-esac-net-annual-epidemiological-report-2023."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Robertson, J., Vlahovi\u0107-Pal\u010devski, V., Iwamoto, K., H\u00f6gberg, L.D., Godman, B., Monnet, D.L., Garner, S., and Weist, K. (2021). ESAC-Net Study Group; WHO Europe AMC Network Study Group. Variations in the consumption of antimicrobial medicines in the European Region. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.765748"},{"key":"ref_21","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2025, December 15). Antimicrobial Prescribing and Stewardship Guidance in Europe, Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/directory-guidance-prevention-and-control\/prudent-use-antibiotics\/antimicrobial."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bogdani\u0107, N., Mo\u010dibob, L., Vidovi\u0107, T., Soldo, A., and Begova\u0107, J. (2022). Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0263437"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e2258","DOI":"10.1002\/rmv.2258","article-title":"Efficacy and safety of azithromycin in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials","volume":"32","author":"Kamel","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"ref_24","unstructured":"European Association of Urology (EAU) (2025, December 15). Guidelines on Urological Infections 2023. Available online: https:\/\/uroweb.org\/guidelines."},{"key":"ref_25","unstructured":"European Medicines Agency (EMA) (2025, December 15). Fluoroquinolone Antibiotics: PRAC Recommendations on Restrictions of Use 2023. Available online: https:\/\/www.ema.europa.eu\/en\/news\/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-10-12-may-2023."},{"key":"ref_26","unstructured":"European Medicines Agency (EMA) (2025, December 15). Systemic and Inhaled Fluoroquinolones: Reminder of Restrictions on Use 2023. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/dhpc\/direct-healthcare-professional-communication-dhpc-systemic-and-inhaled-fluoroquinolone-antibiotics-reminder-restrictions-use_en.pdf."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Feldmeier, G., L\u00f6ffler, C., Altiner, A., Wollny, A., Garbe, K., Kronsteiner, D., K\u00f6ppen, M., Szecsenyi, J., Leyh, M., and Voss, A. (2023). Optimizing antibiotic prescribing for acute respiratory tract infections in German primary care: Results of the CHANGE-3 study. Antibiotics, 12.","DOI":"10.3390\/antibiotics12050850"}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/18\/2\/36\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:58:24Z","timestamp":1776157104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/18\/2\/36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["idr18020036"],"URL":"https:\/\/doi.org\/10.3390\/idr18020036","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}